Literature DB >> 17290223

Impaired DNA damage checkpoint response in MIF-deficient mice.

Alice Nemajerova1, Patricio Mena, Gunter Fingerle-Rowson, Ute M Moll, Oleksi Petrenko.   

Abstract

Recent studies demonstrated that proinflammatory migration inhibitory factor(MIF) blocks p53-dependent apoptosis and interferes with the tumor suppressor activity of p53. To explore the mechanism underlying this MIF-p53 relationship, we studied spontaneous tumorigenesis in genetically matched p53-/- and MIF-/-p53-/- mice. We show that the loss of MIF expression aggravates the tumor-prone phenotype of p53-/- mice and predisposes them to a broader tumor spectrum, including B-cell lymphomas and carcinomas. Impaired DNA damage response is at the root of tumor predisposition of MIF-/-p53-/- mice. We provide evidence that MIF plays a role in regulating the activity of Cul1-containing SCF ubiquitin ligases. The loss of MIF expression uncouples Chk1/Chk2-responsive DNA damage checkpoints from SCF-dependent degradation of key cell-cycle regulators such as Cdc25A, E2F1 and DP1, creating conditions for the genetic instability of cells. These MIF effects depend on its association with the Jab1/CSN5 subunit of the COP9/CSN signalosome. Given that CSN plays a central role in the assembly of SCF complexes in vivo, regulation of Jab1/CSN5 by MIF is required to sustain optimal composition and function of the SCF complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17290223      PMCID: PMC1852846          DOI: 10.1038/sj.emboj.7601564

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

Review 1.  COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases.

Authors:  Gregory A Cope; Raymond J Deshaies
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

Review 2.  The cellular response to general and programmed DNA double strand breaks.

Authors:  Craig H Bassing; Frederick W Alt
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

Review 3.  Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.

Authors:  Davide Rossi; Gianluca Gaidano
Journal:  Hematology       Date:  2002-08       Impact factor: 2.269

Review 4.  Checking on DNA damage in S phase.

Authors:  Jiri Bartek; Claudia Lukas; Jiri Lukas
Journal:  Nat Rev Mol Cell Biol       Date:  2004-10       Impact factor: 94.444

5.  Class switching and Myc translocation: how does DNA break?

Authors:  Paolo Casali; Hong Zan
Journal:  Nat Immunol       Date:  2004-11       Impact factor: 25.606

6.  Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

Authors:  W Krek; M E Ewen; S Shirodkar; Z Arany; W G Kaelin; D M Livingston
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

Review 7.  The role of p53 in tumour suppression: lessons from mouse models.

Authors:  L D Attardi; T Jacks
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

Review 8.  Mechanisms and effectors of MIF-dependent promotion of tumourigenesis.

Authors:  Robert A Mitchell
Journal:  Cell Signal       Date:  2004-01       Impact factor: 4.315

Review 9.  The proto-oncogene c-myc and apoptosis.

Authors:  B Hoffman; D A Liebermann
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

Review 10.  Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis.

Authors:  Luca Busino; Massimo Chiesa; Giulio F Draetta; Maddalena Donzelli
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

View more
  27 in total

1.  Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer.

Authors:  Majid Nabizadeh Marvast; Hamid Reza Sima; Kamran Ghaffarzadehgan; Ali Taghizadeh Kermani; Nona Norouzi
Journal:  J Gastrointest Cancer       Date:  2011-03

2.  Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.

Authors:  Jie Yao; Lin Leng; Maor Sauler; Weiling Fu; Junsong Zheng; Yi Zhang; Xin Du; Xiaoqing Yu; Patty Lee; Richard Bucala
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

3.  Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.

Authors:  Sonja Djudjaj; Ina V Martin; Eva M Buhl; Nina J Nothofer; Lin Leng; Marta Piecychna; Jürgen Floege; Jürgen Bernhagen; Richard Bucala; Peter Boor
Journal:  J Am Soc Nephrol       Date:  2017-08-11       Impact factor: 10.121

4.  Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction.

Authors:  James M Harper; J Erby Wilkinson; Richard A Miller
Journal:  FASEB J       Date:  2010-03-10       Impact factor: 5.191

Review 5.  The biological function and significance of CD74 in immune diseases.

Authors:  Huiting Su; Ning Na; Xiaodong Zhang; Yong Zhao
Journal:  Inflamm Res       Date:  2016-10-17       Impact factor: 4.575

6.  A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.

Authors:  Günter Fingerle-Rowson; Dayananda Rao Kaleswarapu; Corinna Schlander; Nazanin Kabgani; Tania Brocks; Nina Reinart; Raymonde Busch; Anke Schütz; Hongqi Lue; Xin Du; Aihua Liu; Huabao Xiong; Yibang Chen; Alice Nemajerova; Michael Hallek; Jürgen Bernhagen; Lin Leng; Richard Bucala
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

Review 7.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

8.  E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression.

Authors:  Gustavo Palacios; Flaminia Talos; Alice Nemajerova; Ute M Moll; Oleksi Petrenko
Journal:  Cell Cycle       Date:  2008-06-30       Impact factor: 4.534

9.  Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.

Authors:  Eva Verjans; Erik Noetzel; Nuran Bektas; Anke K Schütz; Hongqi Lue; Birgitt Lennartz; Arndt Hartmann; Edgar Dahl; Jürgen Bernhagen
Journal:  BMC Cancer       Date:  2009-07-14       Impact factor: 4.430

10.  Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor.

Authors:  Elliott Taranto; Jin R Xue; Eric F Morand; Michelle Leech
Journal:  J Inflamm (Lond)       Date:  2009-08-24       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.